Akari Therapeutics (AKTX) Goodwill & Intangibles (2014 - 2026)

Akari Therapeutics has disclosed Goodwill & Intangibles across 13 years of filings, most recently posting $38.7 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $38.7 million, down 18.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.7 million (down 18.65% YoY), and the FY2025 annual result was $42.4 million, down 10.82% from the prior year.
• Goodwill & Intangibles came in at $38.7 million for Q1 2026 at Akari Therapeutics, down from $42.4 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $47.6 million in Q1 2025 to a low of $14000.0 in Q4 2023.
• The 5-year median for Goodwill & Intangibles is $42.4 million (2025), against an average of $33.3 million.
• Across the five-year window, Goodwill & Intangibles retreated 25.86% in 2022 and jumped 339757.14% in 2024, its largest moves.
• Akari Therapeutics' Goodwill & Intangibles stood at $17000.0 in 2022, then declined by 17.65% to $14000.0 in 2023, then surged by 339757.14% to $47.6 million in 2024, then dropped by 10.82% to $42.4 million in 2025, then retreated by 8.72% to $38.7 million in 2026.
• The last three Goodwill & Intangibles figures came in at $38.7 million (Q1 2026), $42.4 million (Q4 2025), and $42.4 million (Q3 2025), per Business Quant data.